Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead 2vt Regulatory News (BMD)

Share Price Information for Baronsmead 2vt (BMD)

Share Price is delayed by 15 minutes
Get Live Data
45.00    0.00 (0.00%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £195.03m
BMD Live PriceLast checked at - London Stock Exchange

Intraday Baronsmead 2vt Share Chart

Interim Management Statement

18 Nov 2011 16:11

Baronsmead VCT 3 plc Interim Management Statement

For the three month period from 1 July 2011 to 30 September 2011.

Headlines-

4.5p second interim dividend declared payable on 9 December 2011 to

shareholders on the register as of 25 November 2011 Sale of investment in Quantix at 3.1 times cost

Performance SummaryCapital return As at As at Movement 30 Sep 2011 30 Jun 2011 Total net assets £62.99m £66.70m Net asset value per share 105.41p 108.43p* (2.8%) Share price 95.25p 96.25p (1.0%) Discount to NAV (9.6%) (11.2%) 3 month (%) 1 year (%) 5 years(%) Since launch (%) Net asset valuetotal return (2.7) 9.9 18.0 91.1(1) Share pricetotal return(2) 2.1 15.7 25.4

73.8

FTSE All-sharetotal return(3) (13.5) (4.4) 4.0 25.6

* Stated after allowing for 3.0p interim dividend for comparative purposes. NAV at 30 June 2011 excluding effect of dividend was 111.43p.

Key:

(1) NAV total return = NAV + reinvested dividends; Source: ISIS EP LLP

(2) Share price total return = Mid to mid share price + reinvested dividends;

Source: AIC

(3) FTSE All-share = FTSE All-share Index + reinvested dividends; Source: AIC

These total returns are stated before the inclusion of VCT taxreliefs which are designed to mitigate the higher risks and costs associatedwith investing in smaller companies and the constraints of the VCT legislation.The tax reliefs given at the time of subscription have been 20%, 40%and later 30%, so any adjusted performance measure including this relief willvary depending on the date of subscription. There is the additional benefit ofreceiving VCT dividends tax free.

Investment Performance

The net asset value total return of the company fell 2.7% during the quartercompared to a drop of 13.5% in the FTSE All Share Total Return over the sameperiod. The unquoted valuation movement stayed flat in the quarter while theAIM portfolio fell by 10.3%.Top ten Investments Position Position Percentage at at of NAV 30 Sep 30 June 2011 as at 30 Sep 2011 2011 Company 1 1 Nexus Vehicle Holdings Limited 8.9 2 3 CableCom Networking Holdings 5.9 Limited 3 5 Crew Clothing Company Limited 4.3 4 4 IDOX plc 3.9 5 6 CSC (World) Limited 3.4 6 7 Kaf©vend Holdings Limited 3.2 7 9 Fisher Outdoor Leisure Holdings 2.8 Limited 8 10 Valldata Group Limited 2.6 9 12 Vectura Group plc 2.2 10 15 Inspired Thinking Group Limited 2.0 Total 39.2Analysis of Total Assets Percentage of total Percentage of total assets assets 30 Sep 2011 30 Jun 2011 Unquoted investments 46 47 AIM, Listed & Collective 29 29Investments Interest Bearing 24 23 Securities Net current assets 1 1 Total cash portfolio 25 24 Total Assets 100 100

Analysis of Investment Portfolio by Sector

(excluding cash and interest bearing securities)

Percentage of total Percentage of total investments at investments at 30 Sep 2011 30 Jun 2011 Business Services 35 31 Consumer Markets 18 21 Financial Services 3 2 Healthcare & Education 11 10 IT & Media 33 36 Total 100 100Investment ActivityA total of £4.05m was invested during the period under review: four unquotedinvestments totalling £3.44m, comprising three new and one follow oninvestment, and one AIM traded investment totalling £0.61m. The three newunquoted investments were in acquisition companies led by an experiencedChairman who had previously been backed by ISIS through investment by theBaronsmead VCTs. All three investments delivered successful realisations forshareholders and the three Chairmen are now seeking new opportunities in theirchosen sectors.

After the period end a further unquoted investment of £1.35m was completed in ICCM a provider of high acuity care for home based care users.

A total of £5.57m was realised from the sale or partial sale of four unquotedinvestments and one quoted investment. These sales realised net capital profitsof £2.48m, being 1.8 times the cost of the investments.Investments madeCompany Date Cost (£'000) Escher Group Holdings plc Aug 2011 614 Independent Living Services Limited* Sep 2011 438 Arcas Investments Limited± Sep 2011 1,000 Quest Venture Partners Limited± Sep 2011 1,000 HealthTech Innovation Partners Limited± Sep 2011 1,000 Total investments 4,052*Follow on investment±Acquisition vehiclesRealisationsCompany Date Cost Proceeds Multiple* (£'000) (£'000) Alere Inc Aug 2011 157 108 0.7 Carnell Contractors Aug 2011 558 558 N/ALimited (partial loan redemption) Getting Personal Limited Jul 2011 988 1,811 ND^ MLS Limited (partial loan Sep 2011 188 188 1.0redemption) Quantix Limited Sep 2011 1,194 2,904 3.1 Total realisations 3,085 5,569

* Multiple includes interest and dividends received, loan note redemptions and partial realisations accounted for in prior periods.

^Not disclosed

Net Asset Value

The NAV per share at 31 October 2011 was 105.03p representing a decrease of 0.37p per share (0.35%) since the quarter end as a result of the decrease in the value of the Company's investments in quoted companies.

Events after the period end(to be updated)

Declaration of dividend

The Board has declared a second interim dividend in lieu of a final dividend of4.5p per share, resulting in total dividends for the year of 7.5 per share. Thedividend will be payable on 9 December to shareholders on the register as of 25November 2011. The ex-dividend date will be the 23 November 2011.

New investments

Since 30 September 2011, the Company has invested a total of £1.5m in one newunquoted and one new quoted investment. The Company has investments in 67companies, 21 unquoted and 46 quoted investments and exposure to a further 29companies through the investment in Wood Street Microcap Investment Fund.

Other than the events described above, the Board is not aware of any significant events or transactions which have occurred between 30 September 2011 and the date of publication of this statement which would have a material impact on the financial position of the Company.

Investment objective

Baronsmead VCT 3 plc is a tax efficient listed company which aims to achieve long-term investment returns for private investors.

Further information

Further information regarding the Company, including net asset values published since the end of the period and quarterly factsheets, can be found at the Company's website www.baronsmeadvct3.co.uk

Contact

For further information please contact:

Michael Probin Investor Relations Manager 020 7506 5600 michael.probin@isisep.com

XLON
Date   Source Headline
4th Jun 20263:15 pmRNSNet Asset Value(s)
3rd Jun 202610:15 amRNSNewsletter for the period June 2025 to March 2026
1st Jun 202611:26 amRNSTotal Voting Rights
18th May 20263:45 pmRNSAdmission of Further Securities to Trading
14th May 20262:15 pmRNSAllotment of Shares and Closure of Offer
11th May 20267:00 amRNSNet Asset Value(s)
5th May 20263:15 pmRNSNet Asset Value(s)
1st May 202611:42 amRNSTotal Voting Rights
8th Apr 202610:15 amRNSAdmission of Further Securities to Trading
1st Apr 202611:48 amRNSTotal Voting Rights
31st Mar 20265:37 pmRNSTransaction in Own Shares
30th Mar 20261:50 pmRNSNet Asset Value(s)
24th Mar 20262:25 pmRNSReplacement - Extension to Application Deadline
24th Mar 202612:20 pmRNSApplication Deadline Extension - Fourth Allotment
20th Mar 20267:00 amRNSResult of AGM
11th Mar 20262:00 pmRNSOver-Allotment Facility and Offer Update
5th Mar 20263:30 pmRNSNet Asset Value(s)
2nd Mar 202611:38 amRNSTotal Voting Rights
26th Feb 202612:15 pmRNSAdmission of Further Securities to Trading
20th Feb 202611:02 amRNSDirector/PDMR Shareholding
19th Feb 20264:30 pmRNSAllotment of Shares and Total Voting Rights
17th Feb 20264:05 pmRNSTransaction in Own Shares
6th Feb 202612:06 pmRNSOffer Update:Close of Early Subscription Incentive
5th Feb 20264:15 pmRNSNet Asset Value(s)
2nd Feb 20264:45 pmRNSNet Asset Value(s)
2nd Feb 202610:39 amRNSTotal Voting Rights
29th Jan 20263:35 pmRNSAdmission of Further Securities to Trading
22nd Jan 20263:40 pmRNSAllotment of Shares and Total Voting Rights
12th Jan 202611:35 amRNSPublication of a Supplementary Prospectus
23rd Dec 20257:00 amRNSAnnual Financial Report
23rd Dec 20257:00 amRNSAnnual Financial Report
4th Dec 20253:45 pmRNSNet Asset Value(s)
1st Dec 202510:44 amRNSTotal Voting Rights
20th Nov 20251:22 pmRNSDirector/PDMR Shareholding
20th Nov 202512:00 pmRNSAllotment of Shares and Total Voting Rights
6th Nov 20254:00 pmRNSNet Asset Value(s)
29th Oct 20259:45 amRNSNet Asset Value(s)
13th Oct 20252:00 pmRNSPublication of a Prospectus/Offer for Subscription
1st Oct 20257:00 amRNSTotal Voting Rights
29th Sep 20255:56 pmRNSTransaction in Own Shares
24th Sep 20258:46 amRNSUpdate on Offer for Subscription
23rd Sep 20252:49 pmRNSQuarterly Factsheet June 2025 & Newsletter H2 2025
11th Sep 20256:06 pmRNSTransaction in Own Shares
11th Sep 20255:09 pmRNSDirector/PDMR Shareholding
4th Sep 20253:15 pmRNSNet Asset Value(s)
4th Sep 20258:15 amRNSIntention to Fundraise
6th Aug 20254:15 pmRNSNet Asset Value(s)
31st Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 202510:00 amRNSNet Asset Value(s)
1st Jul 20255:13 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.